1Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients[J]. N Engl J Med,2008,359(23) :2417-2428.
3Neutel JM,Saunders E,Bakris GL,et al. The efficacy and safety of low and high-dose fixed combinations of irbesartan/ hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial [J]. J Clin Hypertens (Greenwich) ,2005,7(10) :578-586.
4Mancia G,de Backer G,Dominiczak A,et al. 2007 Guidelines for the management of arterial hypertension, the task force for the European Society of Hypertension(ESH) and of the European Society of Cardiology (ESC) [J].. J Hypertension, 2007,25 (6) : 1105-1187.
5Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patient with hypertension:principal results of the Hypertension Optimal Treatment (HOT) randomized trial [J]. Lancet, 1998, 351(9118):1755-1762.
6Pepine CJ, Handberg EM, Cooper-Dehoff, et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment stratgy for patients with coronary artery disease. The International Veraparnil-Trandolapril Study ( INVEST ) : a randomized controlled trial [J]. JAMA, 2003, 290 ( 21 ) : 2805- 2816.
